CORMORANT ASSET MANAGEMENT, LP – Stoke Therapeutics, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$13.96M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
-2.80%
quarter
Stoke Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -403K | $12.84 | 1.08M | |
| Q2 2022 | share | 0.00% | 0 shares | -8.52M | $13.21 | 1.08M | |
| Q1 2022 | share | Decrease | -8.00% | -94.55K shares | -5.46M | $21.05 | 1.08M |
| Q4 2021 | share | Decrease | -7.50% | -95.91K shares | -4.15M | $24.07 | 1.18M |
| Q3 2021 | share | 0.00% | 0 shares | -10.50M | $25.44 | 1.27M | |
| Q2 2021 | share | Decrease | -11.10% | -159.53K shares | -12.81M | $33.66 | 1.27M |
| Q1 2021 | share | 0.00% | 0 shares | -33.19M | $38.84 | 1.43M | |
| Q4 2020 | share | Decrease | -6.50% | -100K shares | 37.54M | $61.93 | 1.43M |
| Q3 2020 | share | Decrease | -9.61% | -163.48K shares | 10.95M | $33.49 | 1.53M |
| Q2 2020 | share | Decrease | -0.50% | -8.47K shares | 1.38M | $23.83 | 1.70M |
| Q1 2020 | share | Decrease | -4.41% | -78.87K shares | -11.5M | $22.9 | 1.70M |
| Q4 2019 | share | Increase | +0.01% | 249 shares | 12.22M | $28.32 | 1.78M |
| Q3 2019 | share | Decrease | -4.35% | -81.28K shares | -16.10M | $21.49 | 1.78M |
| Q2 2019 | share | Increase | 0.00% | 1.86M shares | 54.53M | $29.17 | 1.86M |